A comprehensive view of Amgen Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to Amgen on April 23 for "ST2 antigen binding proteins" (American, Canadian Inventors)
Published: April 24, 2024 by U.S. Fed News
Amgen Inc. Prioritizes Patient Care and Environmental Sustainability with Strategic Healthcare Partnerships and Global Advocacy Grants
Published: April 23, 2024 by Industry Intelligence Inc.
Patent Issued for Drug cassette, autoinjector, and autoinjector system (USPTO 11944798)
Published: April 23, 2024 by Biotech Business Daily
Amgen reports it has successfully implemented a hybrid continuous manufacturing process for a commercial lifecycle program; the process has potential to reduce costs and increase efficiency in the biotech industry
Published: April 22, 2024 by Biotech Business Daily
U.S. Patent and Trademark Office Receives Amgen Inc's Patent Application for Tricyclic-Amido-Bicyclic PRMT5 Inhibitors
Published: April 22, 2024 by Pharmaceutical Patent News

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count